Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Regulus Therapeutics Inc patents


Recent patent applications related to Regulus Therapeutics Inc. Regulus Therapeutics Inc is listed as an Agent/Assignee. Note: Regulus Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Regulus Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Regulus Therapeutics Inc-related inventors


Targeting micrornas for metabolic disorders

Described herein are compounds comprising modified oligonucleotides that are complementary to mir-103 and/or mir-107 and methods of treating diseases and disorders using the compounds.. . ... Regulus Therapeutics Inc

Microrna compounds and methods for modulating mir-21 activity

Described herein are compositions and methods for the inhibition of mir-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of mir-21 activity. ... Regulus Therapeutics Inc

Oligomeric compounds and compositions for use in modulation of small non-coding rnas

Compounds, compositions and methods are provided for modulating the expression and function of small non-coding rnas. The compositions comprise oligomeric compounds, targeted to small non-coding rnas. ... Regulus Therapeutics Inc

Methods for treatment of alport syndrome

Provided herein are methods for the treatment of alport syndrome, using modified oligonucleotides targeted to mir-21. In certain embodiments, a modified oligonucleotide targeted to mir-21 improves kidney function and/or reduces fibrosis in subjects having alport syndrome. ... Regulus Therapeutics Inc

Oligomeric compounds and compositions for use in modulation of small non-coding rnas

Compounds, compositions and methods are provided for modulating the expression and function of small non-coding rnas. The compositions comprise oligomeric compounds, targeted to small non-coding rnas. ... Regulus Therapeutics Inc

Microrna compounds and methods for modulating mir-21 activity

Described herein are compositions and methods for the inhibition of mir-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of mir-21 activity. ... Regulus Therapeutics Inc

Microrna compounds and methods for modulating mir-122

Described herein are compositions and methods for the inhibition of mir-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of mir-122 activity. ... Regulus Therapeutics Inc

Targeting micrornas for the treatment of fibrosis

Provided herein are compositions and methods for the modulation of mir-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions.. . ... Regulus Therapeutics Inc

Compounds and methods for enhanced cellular uptake

Described herein are conjugated modified oligonucleotides that are complementary to a target rna. The conjugate facilitates cellular uptake of the modified oligonucleotide, resulting improved potency.. ... Regulus Therapeutics Inc

Targeting micrornas for metabolic disorders

Described herein are compounds comprising modified oligonucleotides that are complementary to mir-103 and/or mir-107 and methods of treating diseases and disorders using the compounds.. . ... Regulus Therapeutics Inc

Oligomeric compounds and compositions for use in modulation of small non-coding rnas

Compounds, compositions and methods are provided for modulating the expression and function of small non-coding rnas. The compositions comprise oligomeric compounds, targeted to small non-coding rnas. ... Regulus Therapeutics Inc

Oligomeric compounds and compositions for use in modulation of small non-coding rnas

Compounds, compositions and methods are provided for modulating the expression and function of small non-coding rnas. The compositions comprise oligomeric compounds, targeted to small non-coding rnas. ... Regulus Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Regulus Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Regulus Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###